Advertisement
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Gender-Specific and Developmental Influences on the Expression of Rat Organic Anion Transporters

Susan C. N. Buist, Nathan J. Cherrington, Supratim Choudhuri, Dylan P. Hartley and Curtis D. Klaassen
Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 145-151; DOI: https://doi.org/10.1124/jpet.301.1.145

Abstract

Rat organic anion transporter 1 (Oat1), Oat2, and Oat3, members of the organic anion transporter family, transport some organic anions across cellular membranes. Previously, highest Oat1 and Oat3 mRNA expression was reported in kidney and Oat2 in liver. However, gender and developmental differences in Oat expression remain unknown. This study describes gender- and age-specific patterns of rat organic anion transporter expression in various tissues. Oat mRNA expression was evaluated in adult male and female Sprague-Dawley rat tissues, and developmental expression was also determined in kidneys of Sprague-Dawley rats ranging in age from days 0 through 45. Expression was quantified using branched-DNA signal amplification. Oat1 mRNA expression was primarily observed in kidney. Surprisingly, Oat2 mRNA expression was also highest in kidney rather than in liver. Moreover, considerably higher Oat2 levels were seen in female kidney as compared with male. Finally, Oat3 mRNA expression was highest in kidney of both genders, whereas a male-predominant pattern was observed in liver. At birth, all kidney Oat mRNA levels were low. Renal Oat1 expression gradually increased throughout development, approaching adult levels at 30 days of age, where at days 40 and 45 Oat1 levels were greater in males than females. Oat2 expression in kidney was minimal through day 30 but increased dramatically at day 35 in females only. Lastly, Oat3 mRNA expression in kidney matured earliest, rapidly increasing from birth through day 10. These data indicate that Oat mRNA expression is primarily localized to the kidney, and observed expression patterns may explain some previously recognized age- and gender-dependent toxicities associated with chemical exposure.

Since the late 1800s, scientists have recognized active transport in the kidney. Studies of p-aminohippurate (PAH) elimination, an analog of hippuric acid, eventually elucidated the tertiary active mechanism of renal organic anion excretion (Pritchard and Miller, 1993). The first step of PAH transport is cleavage of ATP, which provides the energy needed to create a Na+gradient across the basolateral membrane of the proximal tubules. Second, the Na+ gradient drives inwardly directed cotransport of sodium and dicarboxylates, such as α-ketoglutarate, creating a dicarboxylate gradient across the basolateral membrane. Finally, the dicarboxylate gradient fuels the exchange of dicarboxylates out of, and organic anions into, proximal tubule cells. Oat1 mediates the last step in this process.

Oat1 has been characterized in mouse (Lopez-Nieto et al., 1996), rat (Sekine et al., 1997; Sweet et al., 1997), and human (Hosoyamada et al., 1999; Lu et al., 1999; Race et al., 1999) kidney. Furthermore, an immunohistochemical study has localized Oat1 to the renal proximal tubule (Tojo et al., 1999). Comprised of approximately 550 amino acids, the molecular mass of Oat1 is about 56 to 64 kDa. A general characteristic of all of the Oats is that they are postulated to conform to a structure within the membrane that has twelve transmembrane domains (Lopez-Nieto et al., 1996; Sweet et al., 1997; Hosoyamada et al., 1999; Lu et al., 1999; Race et al., 1999). Additionally, there are four potential glycosylation and phosphorylation sites that may be involved in regulation of Oat1 activity (Sekine et al., 1997; Sweet et al., 1997). Substrates of Oat1 span a diverse range of chemical structures, demonstrating the multispecificity of this transporter. Regarding substrate identification, Ullrich and Rumrich (1988) and Fritzsch et al. (1988)have identified the general structural features of Oat1 substrates to include a negative or partial negative charge separated from a second charge by 6 Å and a hydrophobic region 8 Å in length.

Less is known regarding mechanisms and substrates for the other identified Oats, namely Oat2, Oat3, and OAT4. They were first isolated from rat kidney, rat brain, and human kidney, respectively (Simonson et al., 1994; Sekine et al., 1998; Kusuhara et al., 1999; Cha et al., 2000). In contrast to Oat1, these transporters are Na+ independent and cannot betrans-stimulated by α-ketoglutarate or other substrates. Expression of Oat2 has been reported to be primarily localized in liver, whereas expression of both rat Oat3 and human OAT4 mRNA are highest in kidney (Simonson et al., 1994; Sekine et al., 1998; Kusuhara et al., 1999; Cha et al., 2000). Additionally, significant expression of Oat3 and human OAT4 mRNA was reported in brain and placenta, respectively (Kusuhara et al., 1999; Cha et al., 2000).

Renal organic anion transport is crucial in the excretion process of many xenobiotics and endogenous chemicals. Furthermore, age and gender are known to influence pharmacokinetic parameters, such as clearance and half-life of many drugs, as well as the extent of and sensitivity to drug toxicity. Reyes et al. (1998) demonstrated a gender difference in renal transport in which male rats transported more PAH than did females. Moreover, PAH half-life was extended in castrated male rats as compared with intact males. Typical half-life values for PAH were restored with testosterone replacement treatment in castrated rats. Transport differences based on age have also been observed, as in the case of cephalosporin β-lactam antibiotics (Tune, 1975; Fanos and Dall'Agnola, 1999). Some cephalosporin therapies are dose-limited in adults because organic, anionic metabolites of this class of drugs have a high incidence of nephrotoxicity (Tune, 1975). However, toxicity is not apparent in immature human or rodent kidneys, possibly the result of organic anion transport differences between adult and immature kidneys.

Characterization of Oat expression has thus far been determined only in male tissue. Additionally, while Nakajima et al. (2000) have examined developmental expression of Oat1 primarily in embryonic kidney, expression of all three Oats in the postnatal developing kidney has not been examined in detail. Therefore, one goal of this study was to determine Oat1, Oat2, and Oat3 mRNA levels in many tissues of both male and female adult rats. The second objective was to describe Oat mRNA expression during the first 45 days of postnatal development in both the male and female kidney. The results of these experiments may aid in understanding the role of Oats in established gender- and age-specific drug responses and toxicities.

Materials and Methods

Animals

Tissue Expression Study.

Adult male and female Sasco Sprague-Dawley (SD) rats (200–250 g; Charles River Laboratories Inc., Wilmington, MA) were housed according to American Animal Associations Laboratory Animal Care guidelines and acclimated for 1 week. Animals were given free access to water and rat-chow (Teklad; Harlan Sprague Dawley, Inc. Indianapolis, IN). Immediately following decapitation, tissues were removed, frozen in liquid nitrogen, and stored at −80°C.

Developmental Expression Study.

Pregnant Sasco SD rats were purchased at gestation day 13 (Charles River Laboratories Inc.) and housed in an American Animal Associations Laboratory Animal Care accredited facility. Dams were allowed to give birth, and pups remained with their respective dam and litter until weaned and separated at 21 days. Pups were decapitated at ages 0 (date of birth) through day 45 in 5-day increments (n = 5/gender/age). Kidneys were removed immediately following decapitation, frozen in liquid nitrogen, and stored at −80°C.

Total RNA Purification

Total RNA was isolated using RNAzol B reagent (Tel-Test Inc., Friendswood, TX) as per the manufacturer's protocol. RNA pellets were resuspended in diethyl pyrocarbonate-treated deionized water. The concentration of total RNA in each sample was quantified spectrophotometrically at 260 nm. Integrity of each RNA sample was analyzed by formaldehyde-agarose gel electrophoresis (1.2% agarose, 2.1 M formaldehyde in 1× MOPS, 0.5 μg/μl ethidium bromide). Each RNA sample was then visualized under ultraviolet light by ethidium bromide fluorescence.

Development of Specific Oligonucleotide Probe Sets for Branched-DNA (bDNA) Analysis of OATs

The Oat gene sequences of interest were accessed from GenBank and are listed in Table 1. Before development of each probe set, the nucleotide sequences were aligned using CLUSTAL W (Thompson et al., 1994) with software provided by OMIGA (Oxford Molecular Group PLC, Oxford, UK) to determine specific target regions (i.e., nucleotide regions of dissimilarity between Oat sequences) for oligonucleotide probe development. Target sequences were analyzed with ProbeDesigner software version 1.0 (Bayer Corp., Emeryville, CA) for suitability as capture, label, or blocker probes. Multiple specific probes were developed to each Oat mRNA transcript (Table1). All oligonucleotide probes were designed with a melting temperature of approximately 63°C. This enabled hybridization conditions to be held constant (i.e., 53°C) during each hybridization step and for each oligonucleotide probe set. Each probe designed in ProbeDesigner was submitted to the National Center for Biotechnological Information for nucleotide comparison by the basic logarithmic alignment search tool (BLASTn;Altschul et al., 1997) to ensure minimal cross-reactivity with other rat sequences. Oligonucleotides with a high degree of similarity (≥80%) to other rat gene transcripts were eliminated from the design. Probes were synthesized by Operon Technologies (Almeda, CA).

View this table:
Table 1

List of oligonucleotide probes generated for analysis of Oat expression by bDNA signal amplification

bDNA Assay

Specific Oat oligonucleotide probes were diluted in lysis buffer supplied in the HV-QuantiGene bDNA signal amplification kit (Bayer Corp.-Diagnostics Div., Tarrytown, NY). All reagents required for RNA analysis (i.e., lysis buffer, amplifier/label probe buffer, capture hybridization buffer, and substrate solution) were supplied in the HV-QuantiGene bDNA signal amplification kit. Oat1, Oat2, and Oat3 mRNAs were analyzed according to the method of Hartley and Klaassen (2000). Briefly, total RNA (1 μg/μl; 10 μl) was added to each well of a 96-well plate containing capture hybridization buffer (50 μl) and 50 μl of each diluted probe set. Total RNA was allowed to hybridize to each probe set overnight at 53°C. Subsequent hybridization steps were carried out as per the manufacturer's protocol, and luminescence was measured with a Quantiplex 320 bDNA luminometer interfaced with Quantiplex data management software version 5.02 (Bayer Corp.-Diagnostics Div.) for analysis of luminescence from 96-well plates.

Northern Blot Analysis of Rat Oat2 mRNA

Probe Design.

With the exception of probe 1, which was chosen from the 5′-untranslated region, the probes were selected from sequences in the 3′-untranslated region (probe sequences listed below). Four antisense oligonucleotide probes were used to enhance sensitivity of detection (University of Kansas Medical Center, Biotechnology Support Facility, Kansas City, KS). Probes used were 5′-GAC GGT TCA GTC TGC TTA CCA CAT GGA CCC-3′; 5′-CAG GAG CAG CTC CAT CCT TAG GTG GAG GAG-3′; 5′-GTG CTG CGG GAA GTT GTT CTG CTG CTG GAG-3′; and 5′-CCA TGA GCA ACC GTC TTT ATT TAT AGA AGC CCC C-3′.

Blot Procedure.

Antisense oligonucleotide probes were 3′-end labeled using Terminal Transferase (Roche Bioscience, Indianapolis, IN) resulting in an average specific activity of about 5 × 108 cpm/μg DNA. Total RNA was isolated from pooled liver and kidney of approximately 9-week-old male and female SD rats (n = 3/male tissue; n = 5/female tissue), using TRIZOL (Invitrogen, Carlsbad, CA) per the manufacturer's protocol. Poly(A)+ mRNA was subsequently purified from total RNA using an Ambion Poly(A)Pure mRNA isolation kit (Ambion Inc., Austin, TX) per the manufacturer's protocol. Approximately 5 μg of poly(A)+-enriched RNA was electrophoretically resolved in 1% formaldehyde-agarose gel, capillary-blotted overnight onto Zeta-Probe nylon membrane (Bio-Rad, Hercules, CA), UV cross-linked and hybridized at 50°C overnight in ExpressHyb hybridization solution (CLONTECH, Palo Alto, CA). Posthybridization washes were executed at 55°C.

Statistical Analysis

Data were analyzed by the Student's t test (2-tailed, equal variance). Asterisks (∗) indicate a statistical difference (p ≤ 0.05) between genders.

Results

A preliminary screen of pooled RNA (5 rats/gender) from rat adrenal, bladder, blood vessel, brain stem, caudate, cerebellum, cerebral cortex, duodenum, eye, heart, hippocampus, ileum, jejunum, kidney, large intestine, liver, lung, lymph node, mammary tissue, muscle, nasal epithelium, olfactory bulb, ovary, pancreas, pituitary, placenta, prostate, skin, spinal cord, spleen, stomach, testes, thalamus, thymus, thyroid, tongue, and uterus (data not shown) was performed to ensure the major tissues of expression were reported. The 10 tissues of highest expression (cerebellum, cortex, duodenum, ileum, jejunum, kidney, intestine, liver, lung, and stomach) were then examined individually (5 rats/gender). Predominant expression of Oat1 mRNA was in kidney in accordance with previous reports (Lopez-Nieto et al., 1996; Sekine et al., 1997; Sweet et al., 1997). All other tissues expressed minimal levels of this transporter (Fig.1A). Furthermore, a trend emerged in which male kidney levels of Oat1 mRNA were higher than in female kidney, but the difference was not statistically significant. Likewise, highest Oat2 mRNA expression was also in kidney (Fig. 1B), contrary to previous reports (Simonson et al., 1994; Sekine et al., 1998) that identified Oat2 as liver specific. These data indicate that although Oat2 expression in males is highest in liver, expression in female kidney was considerably higher than in male liver. Northern blot analysis of Oat2 further confirmed these results (Fig.2). This female predominance of Oat2 in kidney was not seen in other tissues. Moreover, Oat2 mRNA generally tended to be higher in male than in female tissues, with the exception of kidney. Finally, kidney also contained the highest levels of Oat3 mRNA in comparison to other tissues (Fig. 1C). Oat3 expression was also moderate in brain, lung, and male liver. Although a gender difference was not manifest in kidney, the primary tissue of expression, liver Oat3 mRNA levels were distinctly higher in male than in female rats.

Figure 1
Figure 1

Tissue expression of Oat mRNA. A, Oat1 expression was low in all tissues examined, with the exception of kidney. Additionally, a trend of higher expression in male than female kidney was observed; B, male expression of Oat2 mRNA was highest in liver. However, examination of female expression revealed markedly higher expression in female kidney than male liver; C, Oat3 mRNA was primarily expressed in kidney, with moderate expression in liver. However, a clear gender difference appeared with higher expression in male liver than female liver. ∗, p ≤ 0.05

Figure 2
Figure 2

Oat2 mRNA expression in adult rat liver and kidney. This Northern blot verified Oat2 mRNA expression in female kidney. Four oligonucleotide probes specific to rat Oat2 mRNA were used. Lanes were loaded, from left to right, with poly(A)+-enriched RNA from male liver, male kidney, female liver, and female kidney.

Ontogeny of Oat mRNA was subsequently investigated in kidney because this was the tissue in which all three family members were primarily expressed. Oat1 mRNA expression gradually increased in kidney during the first 30 days of life (Fig. 3A). An Oat1 gender divergence, male expression exceeding that in females, became apparent on days 40 and 45, coinciding with the trend previously observed in the tissue expression study (Fig. 1A). Distinct from Oat1, the amount of Oat2 mRNA remained low through the first 30 postnatal days (Fig. 3B). However, Oat2 expression markedly increased from days 35 through 45 in female rats, without an analogous increase in male expression. Oat3 mRNA expression matured earlier than that of Oat1 or Oat2 in kidney (Fig. 3C). In fact, developmental expression was characterized by a marked increase in Oat3 mRNA during the first 10 days of life without an apparent gender difference during any stage of development.

Figure 3
Figure 3

Developmental expression of Oat mRNA in kidney. A, Oat1 mRNA levels were low at birth (day 0) and increased gradually through day 35. Slightly higher expression in male kidney first became apparent at day 40; B, expression of Oat2 was minimal until day 35, at which time female expression began to increase through day 45. Male expression was constant throughout development; C, Oat3 expression in kidney matured earliest of the three genes, nearing adult levels as early as day 10. ∗, p ≤ 0.05

Discussion

Numerous factors influence toxicity including gender and age. Some xenobiotics follow a gender-specific disposition profile. Diflunisal (a nonsteroidal anti-inflammatory drug) and nilvadipine (a calcium channel antagonist) are two such examples. Clearance of diflunisal is more rapid in males, and females more actively excrete nilvadipine (Macdonald et al., 1990; Zieleniewski et al., 1998). Such differences in clearance can alter the extent of both drug efficacy and toxicity. Also, ages ranging from infancy to senescence may produce a wide spectrum of responses to xenobiotics. Specifically, neonates may experience increased sensitivity to some xenobiotics, whereas other xenobiotics lead to a decreased susceptibility to toxicity as compared with adults. For example, some cephalosporins (e.g., cephaloridine) are nephrotoxic to adults but not infants (Tune, 1975).

During the past century, considerable research efforts have focused on determining the mechanism of active organic anion transport in renal proximal tubules. The model substrate for these studies was PAH because of the nearly complete clearance of this anion after a single pass through the kidneys. In 1997, several groups concurrently cloned and characterized the protein responsible for PAH transport in the kidney (Lopez-Nieto et al., 1996; Sekine et al., 1997; Sweet et al., 1997;Wolff et al., 1997). This protein was named Oat1. An extensive list of substrates has since emerged based primarily on their ability to inhibit radiolabeled PAH transport by oocytes expressing Oat1. Additionally, Oat1 tissue and developmental expression was briefly described. However, tissue expression studies failed to consider female tissues, and developmental characterization was incomplete. Therefore, the aims of this study were to quantitatively describe relative expression of Oat1 mRNA in multiple tissues (of which 10 are shown in Fig. 1) of both male and female SD rats, as well as to determine developmental expression in male and female kidney. Quantification of relative Oat mRNA expression was determined with the bDNA signal amplification method because of the established sensitivity, reproducibility, and wide range of linear response of this method (Hartley and Klaassen, 2000). Furthermore, a direct comparison between DNA polymerase chain reaction and bDNA in the identification of plasma human immunodeficiency virus-1 demonstrated comparable specificity and sensitivity (Rouet et al., 2001).

In agreement with previous reports, kidney expressed more Oat1 mRNA than any other tissue (Lopez-Nieto et al., 1996; Sekine et al., 1997;Sweet et al., 1997; Wolff et al., 1997). Furthermore, renal Oat1 mRNA expression in male rats tended to be higher than in females. This trend paralleled data reported by Reyes et al. (1998) that identified more active PAH transport in male rat renal cortical slices when compared with female slices. Noting that the Oat1 mRNA expression was principally in kidney in this study (Fig. 1A), the next objective was to determine the presence of Oat1 in immature kidneys at several stages of development. A gradually increasing pattern of Oat1 mRNA in male and female kidney was detected (Fig. 3A). Additionally, the possible gender divergence in adult kidneys became apparent at ages 40 and 45 days. A correlation may be drawn between low Oat1 mRNA expression at birth and lack of susceptibility to cephalosporin-induced nephrotoxicity in infants (Fanos and Dall'Agnola, 1999). The hallmark of cephalosporin nephrotoxicity is accumulation of the drug in proximal tubule cells (Tune, 1975). Accumulation is the result of a highly efficient Oat1 cellular influx of cephalosporins from blood coupled with a less efficient efflux transport across the luminal membrane. The developmental pattern of Oat1 mRNA expression may be involved in age-specific nephrotoxicity of drugs such as cephaloridine. Thus, specific gender- and age-dependent patterns of Oat1 mRNA expression directly correlate to the variability of male and female PAH transport in kidneys, as well as to the age-dependent nephrotoxicity of cephalosporins.

Unlike Oat1, only a few studies have addressed the extent of Oat2 expression or identification of substrates for this transporter, which was first cloned in 1994 (Simonson et al., 1994). Previous studies consistently described Oat2 as a liver-specific transporter (Simonson et al., 1994; Sekine et al., 1998). However, these studies were deficient in that they lacked analysis of Oat2 mRNA expression in both male and female tissues, and developmental expression of Oat2 was not addressed in detail. In response to this deficiency, this study was the first to quantitatively identify relative Oat2 mRNA expression in 37 male and female tissues. Surprisingly, Oat2 expression in female kidney was markedly higher than that of all other tissues, including male liver. A Northern blot of male and female Oat2 expression further supported this observation. Therefore, while predominant male expression of Oat2 mRNA was indeed in liver, female Oat2 expression in kidney was substantially higher than that of male liver. The developmental study of Oat2 mRNA further verified this striking gender difference. Analysis of kidney tissue throughout development revealed minimal Oat2 mRNA expression in kidney for the first 30 days, irrespective of gender. However, at the onset of female sexual maturity (approximately day 35), Oat2 mRNA levels in kidney increased dramatically and continued to rise with increasing age. Furthermore, male expression remained low, never changing significantly from day 0 expression levels. Interestingly, pregnant rat Oat2 expression in kidney at gestation day 18 further exceeded adult nonpregnant female expression 1.7-fold (data not shown). Although few Oat2 substrates have been identified, the remarkable gender divergence of renal Oat2 expression suggests an important role in clearance mechanisms of the female kidney. One function of Oat2 could be excretion of conjugated estrogen. Although this has not yet been investigated for Oat2, estrone sulfate was identified as a substrate of Oat3 (Kusuhara et al., 1999). Additionally, anionic metabolites of the antihypertensive drug, nilvadipine, are actively transported by female proximal tubules, whereas male clearance relies primarily on glomerular filtration (Zieleniewski et al., 1998). Together with data reported here, Oat2 may be implicated in proximal tubule transport of this drug.

Oat3, the third member of the rat Oat family, was first isolated from rat choroid plexus (Kusuhara et al., 1999). As with Oat2, there is little knowledge regarding Oat3 substrates, transport mechanism, or biological significance. Also similar to Oat2 is the availability of only cursory information addressing tissue and developmental gene expression. This quantitative analysis of Oat3 mRNA expression throughout the body confirmed the previous report that Oat3 is predominately in kidney (Kusuhara et al., 1999). However, Oat3 transcripts are also moderately expressed in the liver and some regions of the brain. Although expressed to a lesser extent than in kidney, Oat3 may nonetheless be biologically significant in these other tissues. Interestingly, a clear gender difference emerged in hepatic Oat3 expression. Male Oat3 mRNA expression in liver was much higher than in female liver. Unique among the Oats was the early maturation (10 days) of Oat3 transcript levels. Further investigations of the gender-divergent liver expression and the early elevation of OAT3 during kidney development are required to determine the importance of these observations.

In summary, predominant expression of the Oat family members was in kidney. Furthermore, gender differences became apparent in renal Oat1 and Oat2 mRNA levels, as well as hepatic Oat3 mRNA expression. Expression of Oat1 was slightly higher in male kidney than in female kidney, whereas the presence of Oat2 mRNA was considerably higher in female kidney than male kidney or liver, negating the presumed liver specificity of Oat2. Conversely, the Oat3 gender difference occurred in liver, rather than kidney, where male mRNA levels were higher than female levels. Ontogeny data supported the tissue expression results in kidney and identified three distinct maturation patterns. Oat3 matured earliest, whereas Oat1 mRNA expression did not reach adult levels until about day 30. Finally, Oat2 expression was low until the onset of sexual maturity at day 35, when transcript levels began to increase dramatically in females without a similar increase in male expression.

Acknowledgments

We thank Ning Li and Drs. Angela Slitt and Tyra Leazer for technical assistance in this study.

Footnotes

  • Financial support for this research was provided by National Institutes of Health Grants ES-09649, ES-09716, ES-07079, and ES-05883.

  • Abbreviations:
    PAH
    para-aminohippurate
    Oat
    rat organic anion transporter
    OAT
    human organic anion transporter
    MOPS
    4-morpholinepropanesulfonic acid
    SD
    Sprague-Dawley
    bDNA
    branched-DNA method
    • Received October 9, 2001.
    • Accepted December 20, 2001.

References

  1. ↵
    1. Altschul SF,
    2. Madden TL,
    3. Schaffer AA,
    4. Zhang J,
    5. Zhang Z,
    6. Miller W,
    7. Lipman DJ
    (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Cha SH,
    2. Sekine T,
    3. Kusuhara H,
    4. Yu E,
    5. Kim JY,
    6. Kim DK,
    7. Sugiyama Y,
    8. Kanai Y,
    9. Endou H
    (2000) Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275:4507–4512.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Fanos V,
    2. Dall'Agnola A
    (1999) Antibiotics in neonatal infections: a review. Drugs 58:405–427.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Fritzsch G,
    2. Rumrich G,
    3. Ullrich KJ
    (1988) Anion transport through the contraluminal cell membrane of renal proximal tubule: the influence of hydrophobicity and molecular charge distribution on the inhibitory activity of organic anions. Biochim Biophys Acta 978:249–256.
    OpenUrl
  5. ↵
    1. Hartley DP,
    2. Klaassen CD
    (2000) Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology. Drug Metab Dispos 28:608–616.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Hosoyamada M,
    2. Sekine T,
    3. Kanai Y,
    4. Endou H
    (1999) Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 276:F122–F128.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Kusuhara H,
    2. Sekine T,
    3. Utsunomiya-Tate N,
    4. Tsuda M,
    5. Kojima R,
    6. Cha SH,
    7. Sugiyama Y,
    8. Kanai Y,
    9. Endou H
    (1999) Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274:13675–13680.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Lopez-Nieto CE,
    2. You G,
    3. Bush KT,
    4. Barros EJG,
    5. Beier DR,
    6. Nigam SK
    (1996) Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 272:6471–6478.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Lu R,
    2. Chan BS,
    3. Schuster VL
    (1999) Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am J Physiol 276:F295–F303.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Nakajima N,
    2. Sekine T,
    3. Cha SH,
    4. Tojo A,
    5. Hosoyamada M,
    6. Kanai Y,
    7. Yan K,
    8. Awa S,
    9. Endou H
    (2000) Developmental changes in multispecific organic anion transporter 1 expression in the rat kidney. Kidney Int 57:1608–1616.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Macdonald JI,
    2. Herman RJ,
    3. Verbeeck RK
    (1990) Sex-difference and the effects of smoking and oral contraceptive steroids on the kinetics of diflunisal. Eur J Clin Pharmacol 38:175–179.
    OpenUrlPubMed
  12. ↵
    1. Pritchard JB,
    2. Miller DS
    (1993) Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73:765–796.
    OpenUrlFREE Full Text
  13. ↵
    1. Race JE,
    2. Grassl SM,
    3. Williams WJ,
    4. Holtzman EJ
    (1999) Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun 255:508–514.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Reyes JL,
    2. Meléndez E,
    3. Alegrı́a A,
    4. Jaramillo-Juárez F
    (1998) Influence of sex differences on the renal secretion of organic anions. Endocrinology 139:1581–1587.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Rouet F,
    2. Montcho C,
    3. Rouzioux C,
    4. Leroy V,
    5. Msellati P,
    6. Kottan JB,
    7. You B,
    8. Viho I,
    9. Dabis F
    (2001) Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay. AIDS 15:1849–1856.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Sekine T,
    2. Cha SH,
    3. Tsuda M,
    4. Apiwattanakul N,
    5. Nakajima N,
    6. Kanai Y,
    7. Endou H
    (1998) Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 429:179–182.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Sekine T,
    2. Watanabe N,
    3. Hosoyamada M,
    4. Kanai Y,
    5. Endou H
    (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272:18526–18529.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Simonson GD,
    2. Vincent AC,
    3. Roberg KJ,
    4. Huang Y,
    5. Iwanij V
    (1994) Molecular cloning and characterization of a novel liver-specific transport protein. J Cell Sci 107:1065–1072.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Sweet DH,
    2. Wolff NA,
    3. Pritchard JB
    (1997) Expression cloning and characterization of ROAT1: the basolateral organic anion transporter in rat kidney. J Biol Chem 272:30088–30095.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Thompson JD,
    2. Higgins DG,
    3. Gibson TJ
    (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Tojo A,
    2. Sekine T,
    3. Nakajima N,
    4. Hosoyamada M,
    5. Kanai Y,
    6. Kimura K,
    7. Endou H
    (1999) Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 10:464–471.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Tune BM
    (1975) Relationship between the transport and toxicity of cephalosporins in the kidney. J Infect Dis 132:189–194.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Ullrich KJ,
    2. Rumrich G
    (1988) Contraluminal transport systems in the proximal renal tubule involved in secretion of organic anions. Am J Physiol 254:F453–F462.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Wolff NA,
    2. Werner A,
    3. Burkhardt S,
    4. Burckhardt G
    (1997) Expression cloning and characterization of a renal organic anion transporter from winter flounder. FEBS Lett 417:287–291.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Zieleniewski W,
    2. Stêpieñ H,
    3. Zieleniewski J
    (1998) Acute administration of nilvadipine and verapamil inhibits corticosterone secretion and mitotic activity of the adrenal cortex. Med Sci Monit 4:39–42.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Gender-Specific and Developmental Influences on the Expression of Rat Organic Anion Transporters

Susan C. N. Buist, Nathan J. Cherrington, Supratim Choudhuri, Dylan P. Hartley and Curtis D. Klaassen
Journal of Pharmacology and Experimental Therapeutics April 1, 2002, 301 (1) 145-151; DOI: https://doi.org/10.1124/jpet.301.1.145
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement